Delivery Order SPE2DB22D1017-SPE2DB25FYPHZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,705.24 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of December 12, 2025. This non-competitive, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $12,750.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,826.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $28,879.57 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. Issued on November 17, 2025, with an ultimate completion date of November 18, 2025, this firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The contract is being fulfilled from the company's place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $34,691.15 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used in respiratory disease management. The order, issued on September 12, 2025, with completion targeted for September 15, 2025, represents a firm fixed price transaction with no set-aside designation, indicating competitive award through open procurement. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.62 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units) on July 14, 2025, with completion expected by July 15, 2025. This firm fixed price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999.999 billion through December 2026. The product is being delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $10,092.48 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication commonly used in respiratory disease management. The contract is a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. Awarded on July 21, 2025, with completion targeted for July 22, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,604.40 for TRELEGY ELLIPTA 100-62.5-25 (60 count), a combination inhalation powder used in respiratory disease treatment. Issued on September 2, 2025, with an ultimate completion date of September 3, 2025, this firm fixed-price delivery order represents a routine pharmaceutical supply transaction under a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,402.28 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, competitively awarded contract was issued on November 12, 2025, with an ultimate completion date of November 13, 2025. AmerisourceBergen's Corporate Office, located in Conshohocken, Pennsylvania, serves as both the place of performance and the company's...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPHZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,962.10 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was competitively awarded with no set-aside designation, leveraging the vendor's established pharmaceutical supply capabilities. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order draws from AmerisourceBergen's comprehensive $999,999,999.00 IDC vehicle with DLA Troop Support Medical, which extends through December 2026 and authorizes the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for Defense Health Agency and U.S. military healthcare systems. The competitive award of this TRELEGY ELLIPTA order underscores the vendor's demonstrated capability to meet federal procurement requirements and contributes to the DLA's mission of supplying essential medications to military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.0k | 8/27/25 |